ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 48 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $153,759 | +68542.4% | 1,326,654 | 0.0% | 0.00% | – |
| Q4 2022 | $224 | -99.9% | 1,326,654 | -5.4% | 0.00% | – |
| Q3 2022 | $278,000 | -59.4% | 1,403,029 | +2.8% | 0.00% | – |
| Q2 2022 | $684,000 | -7.3% | 1,365,397 | +5.6% | 0.00% | – |
| Q1 2022 | $738,000 | -5.6% | 1,293,316 | 0.0% | 0.00% | – |
| Q4 2021 | $782,000 | -39.5% | 1,293,316 | -3.0% | 0.00% | – |
| Q3 2021 | $1,293,000 | -8.6% | 1,333,913 | +3.7% | 0.00% | – |
| Q2 2021 | $1,414,000 | +39.7% | 1,286,139 | +19.4% | 0.00% | – |
| Q1 2021 | $1,012,000 | +274.8% | 1,076,975 | +92.9% | 0.00% | – |
| Q4 2020 | $270,000 | -31.1% | 558,447 | +11.5% | 0.00% | – |
| Q3 2020 | $392,000 | +9.8% | 500,976 | -24.7% | 0.00% | – |
| Q2 2020 | $357,000 | +58.7% | 664,920 | +5.4% | 0.00% | – |
| Q1 2020 | $225,000 | -74.5% | 630,772 | -49.9% | 0.00% | – |
| Q4 2019 | $882,000 | +272.2% | 1,259,484 | +273.6% | 0.00% | – |
| Q3 2019 | $237,000 | -45.9% | 337,162 | 0.0% | 0.00% | – |
| Q2 2019 | $438,000 | -32.1% | 337,162 | +10.2% | 0.00% | – |
| Q1 2019 | $645,000 | -52.4% | 305,835 | -49.3% | 0.00% | – |
| Q4 2018 | $1,354,000 | +52.8% | 602,660 | +137.9% | 0.00% | – |
| Q3 2018 | $886,000 | +48.2% | 253,331 | +35.4% | 0.00% | – |
| Q2 2018 | $598,000 | -2.0% | 187,055 | +7.2% | 0.00% | – |
| Q1 2018 | $610,000 | -20.6% | 174,557 | 0.0% | 0.00% | – |
| Q4 2017 | $768,000 | -15.8% | 174,557 | 0.0% | 0.00% | – |
| Q3 2017 | $912,000 | +42.5% | 174,557 | +41.8% | 0.00% | – |
| Q2 2017 | $640,000 | +76.3% | 123,113 | +44.1% | 0.00% | – |
| Q1 2017 | $363,000 | +93.1% | 85,464 | +43.2% | 0.00% | – |
| Q4 2016 | $188,000 | -7.8% | 59,694 | 0.0% | 0.00% | – |
| Q3 2016 | $204,000 | +22.2% | 59,694 | 0.0% | 0.00% | – |
| Q2 2016 | $167,000 | -34.3% | 59,694 | +43.6% | 0.00% | – |
| Q1 2016 | $254,000 | +13.4% | 41,564 | 0.0% | 0.00% | – |
| Q4 2015 | $224,000 | +36.6% | 41,564 | 0.0% | 0.00% | – |
| Q3 2015 | $164,000 | -5.7% | 41,564 | 0.0% | 0.00% | – |
| Q2 2015 | $174,000 | +6.7% | 41,564 | 0.0% | 0.00% | – |
| Q1 2015 | $163,000 | -25.6% | 41,564 | +17.0% | 0.00% | – |
| Q4 2014 | $219,000 | +31.9% | 35,529 | 0.0% | 0.00% | – |
| Q3 2014 | $166,000 | -2.4% | 35,529 | 0.0% | 0.00% | – |
| Q2 2014 | $170,000 | +27.8% | 35,529 | +68.8% | 0.00% | – |
| Q1 2014 | $133,000 | – | 21,042 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 1,000,000 | $1,100,000 | 0.07% |
| Hayden Royal, LLC | 40,015 | $44,000 | 0.02% |
| Verdence Capital Advisors LLC | 143,382 | $158,000 | 0.02% |
| Founders Capital Management | 18,000 | $20,000 | 0.01% |
| WOLFF WIESE MAGANA LLC | 10,740 | $12,000 | 0.01% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,622,510 | $1,785,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $25,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 44,000 | $45,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $110,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 97,590 | $107,000 | 0.00% |